EXACT Sciences Corporation Capital Reinvestment Ratio

Latest as of December 2025: 0.21x

EXACT Sciences Corporation capital reinvestment ratio. EXACT Sciences Corporation (EXAS) has a Capital Reinvestment Ratio of 0.21x as of December 2025, meaning it reinvests 0% of its operating cash flow ($151.69 Million) in capital expenditures ($31.24 Million). Check EXACT Sciences Corporation cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.21x
Capex / Operating Cash Flow

Operating Cash Flow

$151.69 Million
USD

Capital Expenditures

$31.24 Million
USD

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of EXACT Sciences Corporation (2020–2025)

Capital reinvestment ratio of EXACT Sciences Corporation from 2020 to 2025. This chart tracks EXACT Sciences Corporation's Capital Reinvestment Ratio across 4 annual periods. Also explore EXACT Sciences Corporation net asset momentum to track the company's year-over-year net asset growth rate.

EXACT Sciences Corporation Capital Reinvestment Ratio by Year (2020–2025)

EXACT Sciences Corporation capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see EXACT Sciences Corporation (EXAS) cash flow conversion.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.27x $491.44 Million $134.66 Million ▼ -57.6%
2024 0.65x $210.54 Million $135.99 Million ▼ -18.8%
2023 0.80x $156.12 Million $124.19 Million ▲ +68.7%
2020 0.47x $136.48 Million $64.35 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow